Patents Assigned to VACARA AB
  • Antibodies to citrullinated proteins
    Patent number: 11866512
    Abstract: The present disclosure concerns antibodies and antibody fragments binding to citrullinated proteins (ACPA), and their use in prevention and treatment of autoimmune diseases, specifically rheumatoid arthritis (RA).
    Type: Grant
    Filed: November 22, 2018
    Date of Patent: January 9, 2024
    Assignee: Vacara AB
    Inventors: Rikard Holmdahl, Theo Rispens, Bingze Xu, Changrong Ge
  • ANTIBODIES TO CITRULLINATED PROTEINS
    Publication number: 20200291133
    Abstract: The present disclosure concerns antibodies and antibody fragments binding to citrullinated proteins (ACPA), and their use in prevention and treatment of autoimmune diseases, specifically rheumatoid arthritis (RA).
    Type: Application
    Filed: November 22, 2018
    Publication date: September 17, 2020
    Applicant: VACARA AB
    Inventors: Rikard HOLMDAHL, Theo RISPENS, Bingze XU, Changrong GE